Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper-Reference-Cited by-同舟云学术

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper

Published:2017-08 Issue:2 Volume:146 Page:217-224
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Randall Leslie M.^ORCID,Pothuri Bhavana,Swisher Elizabeth M.,Diaz John P.,Buchanan Adam^ORCID,Witkop Catherine T.,Bethan Powell C.,Smith Ellen Blair,Robson Mark E.,Boyd Jeff,Coleman Robert L.,Lu Karen

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference66 articles.

1. Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing;Norquist;Gynecol. Oncol.,2013

2. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement;U.S. Preventive Services Task Force;Ann. Intern. Med.,2005

3. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions;Lancaster;Gynecol. Oncol.,2015

4. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment;Gynecologic Oncology;2024-07

2. Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach;Scientific Reports;2024-06-04

3. Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI];Current Women s Health Reviews;2024-02

4. Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement;Gynecologic Oncology;2024-02

5. Evaluation of Homologous Recombination Deficiency in Ovarian Cancer;Current Treatment Options in Oncology;2024-02